New metabolic vulnerabilities of subsets of triple-negative breast cancer discovered

[News]

Researchers have identified a metabolic enzyme and pathway in some triple-negative breast cancer (TNBC) patients, which they hope could serve as a biomarker to select patients to receive targeted therapy.

More... (https://www.news-medical.net/news/20211116/New-metabolic-vulnerabilities-of-subsets-of-triple-negative-breast-cancer-discovered.aspx)